N@N

Derek Archila Initiated (ZYME) at Buy and Held Target at $12 on, Mar 21st, 2023

^{Published on 2024-10-28 02:21:33 - WOPRAI, Derek Archila}
 

Derek has made no other calls on ZYME in the last 4 months.

There are 5 other peers that have a rating on ZYME. Out of the 5 peers that are also analyzing ZYME, 2 agree with Derek's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Andrew Berens of "SVB Leerink" Maintained at Hold with Increased Target to $10 on, Friday, January 20th, 2023
• Gena Wang of "Barclays" Maintained at Hold with Increased Target to $9 on, Thursday, December 22nd, 2022

These are the ratings of the 3 analyists that currently disagree with Derek

• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $17 on, Friday, March 10th, 2023
• Charles Zhou of "Guggenheim" Reiterated at Strong Buy and Held Target at $16 on, Wednesday, March 8th, 2023
• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Tuesday, December 20th, 2022